Developing Digital Therapeutics for Substance Use Disorders (UG3/UH3)
קרן | National Institute on Drug Abuse/NIH |
---|---|
מדינה | U.S.A. |
סוג | Research Grants |
תאריך אחרון | 06/12/2023 |
פקולטה | Engineering, Exact Sciences, Life Sciences, Medicine, Social Sciences |
תיאור | The purpose of this grant is to accelerate the development of Digital Therapeutics (DTx) to treat Substance Use Disorders (SUDs). The primary objective is to move DTxs to their next step in the development process, with the ultimate goal of generating new, FDA authorized, disseminated treatments for SUDs.
Funding: UG3 $500,000 per year; UH3 no fixed limit Duration: UG3- 2 years; UH3- 3 years
Research Authority due date: 10 days prior to submission LOI (encouraged) due dates: 4.7.21, 6.11.21, 4.7.22, 6.11.22, 4.7.23, 6.11.23 Full proposal due dates: 4.8.21, 6.12.21, 4.8.22, 6.12.22, 4.8.23, 6.12.23 |
קבצים מצורפים | |
קישור | לאתר |
עדכון אחרון | עדכון אחרון: 07/04/2021 |